Cargando…

Icariside II: Anticancer Potential and Molecular Targets in Solid Cancers

Icariside II, an active flavonoid, is extracted from the traditional Chinese medicinal herb Epimedii. It possesses multiple biological and pharmacological properties, including anti-inflammatory, anticancer, and anti-osteoporotic properties. In recent years, apoptosis has become the hot spot in anti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Fei, Wu, Qiaolan, Li, Lei, Gong, Jie, Huo, Ran, Cui, Wenqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107468/ https://www.ncbi.nlm.nih.gov/pubmed/33981241 http://dx.doi.org/10.3389/fphar.2021.663776

Ejemplares similares

Icariside II Effectively Reduces Spatial Learning and Memory Impairments in Alzheimer’s Disease Model Mice Targeting Beta-Amyloid Production
por: Yan, Lingli, et al.
Publicado: (2017)

The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II
por: Chen, Meixia, et al.
Publicado: (2016)

Synthesis and Biological Evaluation of Novel Alkyl Amine Substituted Icariside II Derivatives as Potential Anticancer Agents
por: Wu, Tong, et al.
Publicado: (2018)

Icariside II, a Broad-Spectrum Anti-cancer Agent, Reverses Beta-Amyloid-Induced Cognitive Impairment through Reducing Inflammation and Apoptosis in Rats
por: Deng, Yuanyuan, et al.
Publicado: (2017)

Icariside Ⅱ Attenuates Palmitic Acid-Induced Endothelial Dysfunction Through SRPK1-Akt-eNOS Signaling Pathway
por: Gu, Yang-Yang, et al.
Publicado: (2022)

Icariside II, a PDE5 Inhibitor, Suppresses Oxygen-Glucose Deprivation/Reperfusion-Induced Primary Hippocampal Neuronal Death Through Activating the PKG/CREB/BDNF/TrkB Signaling Pathway
por: Xu, Fan, et al.
Publicado: (2020)

Icariside II Restores Vascular Smooth Muscle Cell Contractile Phenotype by Enhancing the Focal Adhesion Signaling Pathway in the Rat Vascular Remodeling Model
por: Lv, Junyuan, et al.
Publicado: (2022)

Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells
por: Khan, Muhammad, et al.
Publicado: (2015)

Icariside II Ameliorates Cognitive Impairments Induced by Chronic Cerebral Hypoperfusion by Inhibiting the Amyloidogenic Pathway: Involvement of BDNF/TrkB/CREB Signaling and Up-Regulation of PPARα and PPARγ in Rats
por: Yin, Caixia, et al.
Publicado: (2018)

Visual Sensing of β-Glucosidase From Intestinal Fungus in the Generation of Cytotoxic Icarisid II
por: Wang, Gang, et al.
Publicado: (2022)

Prophylactic Protective Effects and Its Potential Mechanisms of IcarisideII on Streptozotocin Induced Spermatogenic Dysfunction
por: Xu, Yongde, et al.
Publicado: (2014)

Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats
por: Tian, Wenjie, et al.
Publicado: (2015)

Comparative Pharmacokinetics Study of Icariin and Icariside II in Rats
por: Cheng, Tao, et al.
Publicado: (2015)

AB209. Prophylactic protective effects and its potential mechanisms of icariside II on streptozotocin induced spermatogenic dysfunction
por: Xu, Yongde, et al.
Publicado: (2015)

ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
por: Hou, Jun, et al.
Publicado: (2022)

AB176. Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats
por: Tian, Wenjie, et al.
Publicado: (2015)

TPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer
por: Song, Jie, et al.
Publicado: (2015)

Icariside II enhances cisplatin-induced apoptosis by promoting endoplasmic reticulum stress signalling in non-small cell lung cancer cells
por: Tang, Zhao, et al.
Publicado: (2022)

Identification of Linomide Derivatives as Potential Anticancer Therapeutics using Molecular Docking Studies
por: Borges e Soares, Giselle A., et al.
Publicado: (2022)

Effects of Icariside II on Corpus Cavernosum and Major Pelvic Ganglion Neuropathy in Streptozotocin-Induced Diabetic Rats
por: Bai, Guang-Yi, et al.
Publicado: (2014)

Aconiti Lateralis Radix Praeparata as Potential Anticancer Herb: Bioactive Compounds and Molecular Mechanisms
por: Zhang, Wen, et al.
Publicado: (2022)

Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats
por: Wang, Lin, et al.
Publicado: (2015)

Selective Acetogenins and Their Potential as Anticancer Agents
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2019)

Anticancer applications of phytochemicals in gastric cancer: Effects and molecular mechanism
por: Liang, Zhaofeng, et al.
Publicado: (2023)

JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
por: Rah, Bilal, et al.
Publicado: (2022)

Urokinase receptor and resistance to targeted anticancer agents
por: Gonias, Steven L., et al.
Publicado: (2015)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone
por: Liu, Weidong, et al.
Publicado: (2016)

Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials
por: Xu, Cangcang, et al.
Publicado: (2020)

Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors
por: Chang, Wen-I, et al.
Publicado: (2022)

AB208. Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats
por: Wang, Lin, et al.
Publicado: (2015)

MicroRNA as an Important Target for Anticancer Drug Development
por: Fu, Zhiwen, et al.
Publicado: (2021)

Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
por: Ramer, Robert, et al.
Publicado: (2019)

Formononetin: A Review of Its Anticancer Potentials and Mechanisms
por: Tay, Kai-Ching, et al.
Publicado: (2019)

Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells
por: Uludağ, Damla, et al.
Publicado: (2022)

Capsaicin Potentiates Anticancer Drug Efficacy Through Autophagy-Mediated Ribophorin II Downregulation and Necroptosis in Oral Squamous Cell Carcinoma Cells
por: Huang, Yi-Ching, et al.
Publicado: (2021)

Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
por: Zhang, Meng, et al.
Publicado: (2022)

AB184. Icariside II induces NO production in human cavernous endothelial cells via the activation of eNOS by miR-155
por: Lei, Hongen, et al.
Publicado: (2015)

Icariside II induces rapid phosphorylation of endothelial nitric oxide synthase via multiple signaling pathways
por: Song, Wenpeng, et al.
Publicado: (2022)

Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
por: Porporato, Paolo E., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5gb2q7i90cpeu9ac9rmre78iec